Ali M. Alrumaih

Drug shortages in Saudi Arabia: Root causes and recommendations

Yazed AlRuthia, Monira Alwhaibi, Mashal F. Alotaibi et al. · Saudi Pharmaceutical Journal · 2018 · 59 citations · Full text

Pharmacy, Pharmacy Practice, Pharmaceutical Care +13

The Impact of COVID-19 on Essential Medicines and Personal Protective Equipment Availability and Prices in Saudi Arabia

Rana Aljadeed, Yazed AlRuthia, Bander Balkhi et al. · Healthcare · 2021 · 51 citations · Full text

Pharmacy, Hospital Pharmacy, Drug Utilization Review +13

COVID-19 and Saudi Arabia public financing of prescription drugs: An opportunity for reform

Yazed AlRuthia, Sulaiman A. Alrashed, Bander Balkhi et al. · Health Policy and Technology · 2020 · 11 citations

Public Affairs, Health Policy, Pharmaceutical Policy +14

Real-World Impact of Switching From Insulin Glargine (Lantus®) to Basaglar® and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia

Yazed AlRuthia, Ohud H. Bahari, Suliman Alghnam et al. · Frontiers in Public Health · 2022 · 11 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Efficacy and Safety of Empagliflozin in Type 2 Diabetes Mellitus Saudi Patients as Add-On to Antidiabetic Therapy: A Prospective, Open-Label, Observational Study

Fahad M. Althobaiti, Safaa Alsanosi, Alaa Hisham Falemban et al. · Journal of Clinical Medicine · 2022 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17